The honest framing is that they are not interchangeable, and the better one for a given patient depends on the patient
Tirzepatide Research Overview Built as a dual GIP and GLP-1 receptor agonist, Tirzepatide is extensively studied for its influence on metabolism, appetite regulation, and glucose balance
Tirzepatide is a dual GIP/GLP-1 This compound is strictly intended for research purposes only and is not approved for human consumption
While GLP-1 RAs were the first to reach the market, primarily due to the serendipitous discovery of exendin-4, GLP-1 is only one of many hormones that modulate glucose metabolism and regulate appetite
Some women experience changes in menstrual patterns, hot flashes, or mood during aggressive weight loss
This comes from stability data on the FDA-approved formulation of tirzepatide (Mounjaro and Zepbound), which compounding pharmacies use as a reference point for their own formulations